<DOC>
	<DOCNO>NCT00412256</DOCNO>
	<brief_summary>The primary hypothesis constitute fish-oil preparation ( Omegaven ) superior preparation base Soja-oil ( Lipovenös ) reduce sign symptoms patient active rheumatoid arthritis .</brief_summary>
	<brief_title>Omegaven Patients With Rheumatoid Arthritis ( ORA-Trial )</brief_title>
	<detailed_description>The study consider phase III trial ( comparison two licensed preparation non-approved indication ) . This control double blind trial aim compare effect parenterally apply fat emulsion disease activity RA patient , express change DAS28 . To test hypothesis patient randomize treated 2ml/kg bodyweight preparation seven consecutive day . These treatment cycle repeat four time monthly interval . For improve patient ( DAS28 decrease &lt; 0.6 ) escape third fourth treatment cycle foreseen . In case escape patient treat Omegaven open manner . Efficacy parameter comprise DAS28 , ACR-criteria , M-HAQ , SF-36 , co-medication consumption . To assess safety laboratory parameter , comprise , LFT , KFT , CBC , fast glucose , cholesterol , HDL , LDL , neutral fat , urinary analysis perform . Moreover , blood pressure control clinically examination perform regular basis . Study recruitment start fall 2004 complete November 2006 .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>write informed consent RA accord ACR criterion active RA ( DAS28 &gt; 4.0 ) screen visit insignificant DAS28change ( &lt; 0.6 ) screen first intervention age low 18 yr . pregnancy insufficient birth control lactation army service lack independence relevant therapeutic dietary change last three month relevant therapeutic dietary change foresee study duration ( include surgery ) application Omega3 fatty acids last three month application Omega3 fatty acid intend study duration prednisolone &gt; 10 mg/day contraindication Omegaven Lipovenös ( accord label )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>Treatment</keyword>
	<keyword>Disease activity</keyword>
	<keyword>Clinical trial</keyword>
</DOC>